uniQure NV
QURE
23.14
+0.08
+0.35%
uniQure NV
US · QURE
#2954 by market cap
Listed 1970
23.14
+0.08
+0.35%
Live - 5344 symbols - heartbeat 32s ago
· 2026-10-08 07:49
Pre-market
22.86
-1.21%
After-hours
23.07
-0.30%
Overnight
22.85
-1.25%
- Market cap
- 1.61B
- P/E (TTM)i
- -5.70
- P/Bi
- 4.95
- EPSi
- -3.46
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on QURE?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Barclays Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $65Market Newswire · 2026/6/23
-
Rating change
Analysts' Top Healthcare Picks: UniQure (QURE), Alumis Inc. (ALMS)TipRanks · 2026/9/3
-
Rating change
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)TipRanks · 2026/7/30
-
Barclays Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $28Market Newswire · 2026/10/6
-
Barclays Downgrades UniQure NV(QURE.US) to Hold Rating, Cuts Target Price to $28Market Newswire · 2026/10/5
-
Stifel Maintains UniQure NV(QURE.US) With Buy RatingMarket Newswire · 2026/9/29
-
Rating change
H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $80Market Newswire · 2026/7/31
-
Rating change
H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $80Market Newswire · 2026/6/29
-
Rating change
William Blair Upgrades UniQure NV(QURE.US) to Buy RatingMarket Newswire · 2026/9/2
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: UniQure (QURE), Biohaven Ltd. (BHVN)TipRanks · 2026/6/18
-
Rating change
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $46 to $68Market Newswire · 2026/7/30
-
Rating change
Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $75Market Newswire · 2026/9/3
-
Rating change
Mizuho Securities Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $68Market Newswire · 2026/6/25
-
Rating change
Goldman Sachs Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $46Market Newswire · 2026/7/30
-
Rating change
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $46 to $70Market Newswire · 2026/6/18
-
RBC Capital Maintains UniQure NV(QURE.US) With Buy Rating, Cuts Target Price to $48Market Newswire · 2026/10/2
-
Rating change
Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $71Market Newswire · 2026/8/14
-
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $31 to $80Market Newswire · 2026/9/30
-
Rating change
Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $71Market Newswire · 2026/6/22
-
Rating change
TD Cowen Maintains UniQure NV(QURE.US) With Buy RatingMarket Newswire · 2026/9/3
-
Rating change
RBC Capital Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/5/7
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:49:20 · For reference only, not investment advice and not tailored to your situation.